anonymous
Guest
anonymous
Guest
shut up bitchI think you are delusional at best! You could write a fiction novel your so good haha! No this is not Ann Arbor here.
With what comes out of the Outcomes in March(bempedoic acids absolute RR) and what Outcomes shows in certain subgroups of patients this could be either a BLOCKBUSTER MOA that will lead to how physicians prescribe LDL-C lowering (hopefully primary prevention indication) in the future OR a DUD with the Outcomes showing no better benefit compared to how physicians are treating now..
It is no wonder why the ACC has this trial as a TOP/LATE BREAKER first day presentation.
Hold on the your seatbelts!